Mei Pharma Revenue, Growth & Competitor Profile

DBA MARSHALL EDWARDS, INC.

Company Profile & Annual Report for Mei Pharma

Access the complete profile.

Mei Pharma Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	11455 El Camino Real Ste 250 San Diego, CA 92130

Mei Pharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Mei Pharma's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Mei Pharma is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Mei Pharma is a publicly traded company on NCM using the ticker symbol MEIP. Detailed information on company financials and operating reports can be found here: NCM: MEIP

Mei Pharma Annual Revenue and Growth Rate

Mei Pharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Mei Pharma's revenues are gauged from an analysis of company filings.

Investor Activity

Mei Pharma has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
May 30, 2018	20	100%	$75 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Mei Pharma is developing and marketing. Mei Pharma doesn't have any recent trademark applications, indicating Mei Pharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ZANOVERSE pharmaceutical products for the treatment of cancer and immune-related diseases and disorders; pharmaceuticals for use in the treatment of oncological disorders and diseases and immune-related diseases and disorders	01/25/2021
ZANPHOS pharmaceutical products for the treatment of cancer and immune-related diseases and disorders; pharmaceuticals for use in the treatment of oncological disorders and diseases and immune-related diseases and disorders	07/10/2020
MEI PHARMA Pharmaceuticals for use in the treatment of oncological disorders, neurological disorders, and immune-related disorders	03/21/2012

See all trademarks and details in the Full Report.

Market Share of Mei Pharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Mei Pharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Mei Pharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ILLUMINA	San Diego, CA	100
NEUROCRINE BIOSCIENCES	San Diego, CA	23
SANTARUS	San Diego, CA	16
HALOZYME THERAPEUTICS	San Diego, CA	15
MIRATI THERAPEUTICS	San Diego, CA	12
FATE THERAPEUTICS	San Diego, CA	11

Future Competition: Mei Pharma's Fastest Growing Competitors

These companies are in the same general field as Mei Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)